Posts

Showing posts from March, 2022

Hyper-accurate positioning

  We all use GPS every day; it has transformed our lives and many of our businesses. But while today’s GPS is accurate to within 5 to 10 meters, new hyper-accurate positioning technologies have accuracies within a few centimeters or millimeters. That’s opening up new possibilities, from landslide warnings to delivery robots and self-driving cars that can safely navigate streets. China’s BeiDou (Big Dipper) global navigation system was completed in June 2020 and is part of what’s making all this possible. It provides positioning accuracy of 1.5 to two meters to anyone in the world. Using ground-based augmentation, it can get down to millimeter-level accuracy. Meanwhile, GPS, which has been around since the early 1990s, is getting an upgrade: four new satellites for GPS III launched in November and more are expected in orbit by 2023. 

Data trusts

  Technology companies have proven to be poor stewards of our personal data. Our information has been leaked, hacked, and sold and resold more times than most of us can count. Maybe the problem isn’t with us, but with the model of privacy to which we’ve long adhered—one in which we, as individuals, are primarily responsible for managing and protecting our own privacy. Data trusts offer one alternative approach that some governments are starting to explore. A data trust is a legal entity that collects and manages people’s personal data on their behalf. Though the structure and function of these trusts are still being defined, and many questions remain, data trusts are notable for offering a potential solution to long-standing problems in privacy and security.

Messenger RNA vaccines

Image
  We got very lucky. The two most effective vaccines against the coronavirus are based on messenger RNA, a technology that has been in the works for 20 years. When the covid-19 pandemic began last January, scientists at several biotech companies were quick to turn to mRNA as a way to create potential vaccines; in late December 2020, at a time when more than 1.5 million had died from covid-19 worldwide, the vaccines were approved in the US, marking the beginning of the end of the pandemic. The new covid vaccines are based on a technology never before used in therapeutics, and it could transform medicine, leading to vaccines against various infectious diseases, including malaria. And if this coronavirus keeps mutating, mRNA vaccines can be easily and quickly modified. Messenger RNA also holds great promise as the basis for cheap gene fixes to sickle-cell disease and HIV. Also in the works: using mRNA to help the body fight off cancers.